Insider Transactions in Q2 2024 at Ocuphire Pharma, Inc. (OCUP)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+18.57%
|
-
|
|
Jun 11
2024
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+14.68%
|
-
|
|
Jun 11
2024
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+22.71%
|
-
|
|
Jun 11
2024
|
Cam Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+34.81%
|
-
|
|
Jun 11
2024
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+23.76%
|
-
|
|
Jun 11
2024
|
Sean Ainsworth |
BUY
Grant, award, or other acquisition
|
Direct |
41,143
+31.77%
|
-
|
|
May 22
2024
|
Ashwath Jayagopal Chief Scientific & Dev. Ofc. |
BUY
Open market or private purchase
|
Direct |
3,500
+4.27%
|
$3,500
$1.76 P/Share
|
|
May 17
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.15%
|
$5,000
$1.75 P/Share
|
|
Apr 11
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+18.68%
|
-
|